Zai Lab (ZLAB) Other financing activities (2020 - 2025)

Zai Lab's (ZLAB) quarterly Other financing activities came in at -$660000.0 in Q4 2025, down 177.28% quarter-over-quarter from $854000.0 in Q1 2025.

Zai Lab (ZLAB) Other financing activities (2020 - 2025) Analysis & Trends

Zai Lab has disclosed Other financing activities across 4 years of filings, most recently posting -$660000.0 for Q4 2025.

  • Other financing activities for Q4 2025 came in at -$660000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$660000.0 (down 177.28% YoY), and the FY2025 annual result was $194000.0, down 72.29% from the prior year.
  • Other financing activities came in at -$660000.0 for Q4 2025 at Zai Lab, down from $854000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $973000.0 in Q1 2021 to a low of -$700000.0 in Q2 2024.
  • The 3-year median for Other financing activities is $513000.0 (2021), against an average of $303444.4.
  • Peak annual rise in Other financing activities reached 2592.31% in 2021, while the deepest fall reached 99.98% in 2021.
  • Zai Lab's Other financing activities stood at $1000.0 in 2021, then soared by 69900.0% to $700000.0 in 2024, then sank by 194.29% to -$660000.0 in 2025.
  • The last three Other financing activities figures came in at -$660000.0 (Q4 2025), $854000.0 (Q1 2025), and $700000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -660,000.00
Dec 31, 2025 -660,000.00
Mar 31, 2025 854,000.00
Mar 31, 2025 854,000.00
Sep 30, 2024 700,000.00
Sep 30, 2024 700,000.00
Jun 30, 2024 -700,000.00
Jun 30, 2024 -700,000.00
Mar 31, 2024 700,000.00
Mar 31, 2024 700,000.00
Dec 31, 2021 1,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 513,000.00
Sep 30, 2021 513,000.00
Jun 30, 2021 350,000.00
Jun 30, 2021 350,000.00
Mar 31, 2021 973,000.00
Mar 31, 2021 973,000.00
Dec 31, 2020 4.11 Mn
Dec 31, 2020 4.11 Mn